SEARCH BY
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 137 |
| Revenue | 98M USD (2024) |
Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Nektar was founded in 1990 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2005 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-04 |
Nektar - Commercial PEGylation Reagent Manufacturing Business
Huntsville, Alabama, United States Nektar's Commercial PEGylation Reagent Manufacturing Business site is a 124,000-square-foot, commercial-scale specialized manufacturing facility. Nektar's Commercial PEGylation Reagent Manufacturing Business is based in Huntsville, Alabama. |
Sell | $90M |